Stock PHARM PHARMING GROUP N.V.
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report

Pharming Group N.V. Stock price

Equities

PHARM

NL0010391025

Pharmaceuticals

Real-time Euronext Amsterdam
Other stock markets
 11:39:56 2023-09-27 am EDT 		Intraday chart for Pharming Group N.V. 5-day change 1st Jan Change
1.208 EUR -0.90% -4.35% +11.44%
Sep. 25 Transcript : Pharming Group N.V. - Shareholder/Analyst Call CI
Sep. 22 ADRs Advance, Warrantee Inc. Climbs 20.0% DJ

Financials

Sales 2023 * 207 M 218 M Sales 2024 * 258 M 271 M Capitalization 796 M 837 M
Net income 2023 * -22 M -23 M Net income 2024 * -4 M -4 M EV / Sales 2023 *
3,54x
Net cash position 2023 * 63 M 66 M Net cash position 2024 * 78 M 82 M EV / Sales 2024 *
2,78x
P/E ratio 2023 *
-42,3x
P/E ratio 2024 *
559x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float97.27%
More Fundamentals * Assessed data

Chart Pharming Group N.V.

Dynamic Chart

Latest news about Pharming Group N.V.

Transcript : Pharming Group N.V. - Shareholder/Analyst Call CI
ADRs Advance, Warrantee Inc. Climbs 20.0% DJ
ADRs Close Lower; Quantasing Group Ltd. Declines 33.5% DJ
Pharming Group N.V. Announces First Patient Enrolled in Phase Iii Clinical Trial of Leniolisib for the Treatment of Apds in Japan CI
Pharming Seeks Acquisitions CI
Transcript : Pharming Group N.V., Q2 2023 Earnings Call, Aug 03, 2023 CI
Pharming Group N.V. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Pharming Group N.V. Appoints Alexander Breidenbach as Chief Business Officer CI
Pharming Group Nominates Richard Peters as Chairman MT
Pharming Group to Sell Rare Pediatric Disease Priority Review Voucher to Novartis for About $21.1 Million MT
Pharming Group N.V. Approves the Proposal to Reappoint Paul Sekhri, Chair of the Board, as Non-Executive Director for A Period of One Year Who Will Resign from the Board Upon Appointment of His Successor CI
Transcript : Pharming Group N.V. - Shareholder/Analyst Call CI
Sector Update: Health Care Stocks Steady Premarket Thursday MT
Sector Update: Health Care MT
Transcript : Pharming Group N.V., Q1 2023 Earnings Call, May 11, 2023 CI
More news

Analyst Recommendations on Pharming Group N.V.

Oppenheimer Adjusts Pharming Group Price Target to $40 From $36, Maintains Outperform Rating MT
Oppenheimer Adjusts Pharming Group's Price Target to $36 From $43, Maintains Outperform Rating MT
Van Leeuwenhoeck issues research note on Pharming (PHAR.AS): Turning the Page PU
More recommendations

Press releases Pharming Group N.V.

Pharming N : EGM 2023 presentation PU
Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders GL
Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders AQ
Presentation: H.C. Wainwright 25th Annual Global Investment Conference, September 11-13, 2023 PU
Pharming N : Halfjaarlijkse financiële verslaggeving PU
More press releases

News in other languages on Pharming Group N.V.

Tech zet AEX in het rood
Tech onder druk op rood Damrak
Aandeelhouders Pharming akkoord met benoeming nieuwe bestuursvoorzitter
Beursagenda: Nederlandse bedrijven
Beursagenda: Nederlandse bedrijven
More news

Quotes and Performance

1 day-0.90%
1 week-4.35%
Current month+2.98%
1 month+2.29%
3 months+14.94%
6 months+6.24%
Current year+11.44%
More quotes

Highs and lows

1 week
1.19
Extreme 1.192
1.26
1 month
1.14
Extreme 1.143
1.31
Current year
0.89
Extreme 0.8945
1.42
1 year
0.89
Extreme 0.8945
1.42
3 years
0.66
Extreme 0.6576
1.50
5 years
0.66
Extreme 0.6576
1.64
10 years
0.11
Extreme 0.111
1.64
More quotes

Managers and Directors - Pharming Group N.V.

Managers TitleAgeSince
Sijmen de Vries CEO
 Chief Executive Officer 64 2008
Jeroen Henk Wakkerman DFI
 Director of Finance/CFO 54 2020
Ruud van Outersterp CMP
 Compliance Officer 59 2021
Members of the board TitleAgeSince
Sijmen de Vries BRD
 Director/Board Member 64 2021
Leonard Kruimer BRD
 Director/Board Member 65 2021
Deborah Jorn BRD
 Director/Board Member 65 2019
More insiders

Quotes

Date Price Change Volume
23-09-27 1.208 -0.90% 2,193,144
23-09-26 1.219 +0.49% 4,807,987
23-09-25 1.213 +0.25% 3,767,313
23-09-22 1.210 -0.82% 5,902,441
23-09-21 1.220 -3.40% 7,608,333

Real-time Euronext Amsterdam, September 27, 2023 at 11:39 am EDT

More quotes

Company Profile

Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The Group is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming Group N.V. serves patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia/Pacific.
Sector
Pharmaceuticals
Calendar
10:20am - Cantor Global Healthcare Conference
More about the company

Income Statement Evolution

More financial data

Ratings for Pharming Group N.V.

Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.208EUR
Average target price
1.863EUR
Spread / Average Target
+54.18%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi. (M$)
PHARMING GROUP N.V. Stock Pharming Group N.V.
+11.44% 850 M $
SICHUAN HUIYU PHARMACEUTICAL CO., LTD. Stock Sichuan Huiyu Pharmaceutical Co., Ltd.
-3.66% 845 M $
INNOVIVA, INC. Stock Innoviva, Inc.
-0.60% 857 M $
SOSEI GROUP CORPORATION Stock Sosei Group Corporation
-27.69% 838 M $
SHANXI ZHENDONG PHARMACEUTICAL CO.,LTD Stock Shanxi Zhendong Pharmaceutical Co.,Ltd
-18.79% 833 M $
LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. Stock Luoxin Pharmaceuticals Group Stock Co., Ltd.
-26.47% 827 M $
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED Stock Sun Pharma Advanced Research Company Limited
+8.32% 872 M $
CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD. Stock Chengdu Easton Biopharmaceuticals Co., Ltd.
-11.41% 876 M $
HAINAN HAIYAO CO., LTD. Stock Hainan Haiyao Co., Ltd.
+10.30% 823 M $
SHANDONG LUKANG PHARMACEUTICAL CO.,LTD. Stock Shandong Lukang Pharmaceutical Co.,Ltd.
-6.06% 821 M $
Other Pharmaceuticals
  1. Markets
  2. Equities
  3. Stock Pharming Group N.V. - Euronext Amsterdam
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer